Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Unicentric Comparing Effectiveness Superiority of to Clemastine Fumarate 1, 0 mg/g + Dexamethasone 0, 5 mg/g to Dexchlorpheniramine Maleate 10 mg/g in Eczema Treatment.

NCT01257061 is registered in ClinicalTrials.gov with EMS as lead sponsor.

NCT NCT01257061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01257061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Unicentric Comparing Effectiveness Superiority of to Clemastine Fumarate 1, 0 mg/g + Dexamethasone 0, 5 mg/g to Dexchlorpheniramine Maleate 10 mg/g in Eczema Treatment.
Lead sponsor
EMS
Phase
Phase 3
Overall status
Completed
Start date
September 6, 2012
Completion date
August 2, 2013
Enrollment
310 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eczema